Literature DB >> 23523177

Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation.

Hiroshi Wakao1, Kazunori Yoshikiyo, Uichi Koshimizu, Tomoko Furukawa, Kei Enomoto, Tomomi Matsunaga, Tomofumi Tanaka, Yusuke Yasutomi, Takashi Yamada, Hisanori Minakami, Jyunji Tanaka, Atsushi Oda, Tomoyuki Sasaki, Rika Wakao, Olivier Lantz, Tadashi Udagawa, Yukie Sekiya, Kazue Higuchi, Nobuyuki Harada, Ken Nishimura, Manami Ohtaka, Mahito Nakanishi, Hiroyoshi Fujita.   

Abstract

Mucosal-associated invariant T (MAIT) cells play an important physiological role in host pathogen defense and may also be involved in inflammatory disorders and multiple sclerosis. The rarity and inefficient expansion of these cells have hampered detailed analysis and application. Here, we report an induced pluripotent stem cell (iPSC)-based reprogramming approach for the expansion of functional MAIT cells. We found that human MAIT cells can be reprogrammed into iPSCs using a Sendai virus harboring standard reprogramming factors. Under T cell-permissive conditions, these iPSCs efficiently redifferentiate into MAIT-like lymphocytes expressing the T cell receptor Vα7.2, CD161, and interleukin-18 receptor chain α. Upon incubation with bacteria-fed monocytes, the derived MAIT cells show enhanced production of a broad range of cytokines. Following adoptive transfer into immunocompromised mice, these cells migrate to the bone marrow, liver, spleen, and intestine and protect against Mycobacterium abscessus. Our findings pave the way for further functional analysis of MAIT cells and determination of their therapeutic potential.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23523177     DOI: 10.1016/j.stem.2013.03.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  45 in total

1.  NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells.

Authors:  Akhilesh Kumar; Jeong Hee Lee; Kran Suknuntha; Saritha S D'Souza; Abir S Thakur; Igor I Slukvin
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

Review 2.  New cell sources for T cell engineering and adoptive immunotherapy.

Authors:  Maria Themeli; Isabelle Rivière; Michel Sadelain
Journal:  Cell Stem Cell       Date:  2015-04-02       Impact factor: 24.633

3.  Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells.

Authors:  Ras Trokovic; Jere Weltner; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Veikko Salomaa; Anu Jalanko; Timo Otonkoski; Aija Kyttälä
Journal:  Stem Cells Transl Med       Date:  2014-10-29       Impact factor: 6.940

Review 4.  iPS cells: a game changer for future medicine.

Authors:  Haruhisa Inoue; Naoki Nagata; Hiromi Kurokawa; Shinya Yamanaka
Journal:  EMBO J       Date:  2014-02-05       Impact factor: 11.598

Review 5.  Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy.

Authors:  Sunny J Patel; Takayoshi Yamauchi; Fumito Ito
Journal:  Surg Oncol Clin N Am       Date:  2019-04-10       Impact factor: 3.495

6.  Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory.

Authors:  Hidehito Saito; Keisuke Okita; Alfred E Chang; Fumito Ito
Journal:  Cancer Res       Date:  2016-04-12       Impact factor: 12.701

Review 7.  Nonclassical T cells and their antigens in tuberculosis.

Authors:  Gennaro De Libero; Amit Singhal; Marco Lepore; Lucia Mori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-24       Impact factor: 6.915

Review 8.  Rise of iPSCs as a cell source for adoptive immunotherapy.

Authors:  Atsutaka Minagawa; Shin Kaneko
Journal:  Hum Cell       Date:  2014-02-09       Impact factor: 4.174

Review 9.  Cloning and expansion of antigen-specific T cells using iPS cell technology: development of "off-the-shelf" T cells for the use in allogeneic transfusion settings.

Authors:  Hiroshi Kawamoto; Kyoko Masuda; Seiji Nagano; Takuya Maeda
Journal:  Int J Hematol       Date:  2018-01-31       Impact factor: 2.490

Review 10.  Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases.

Authors:  Chie Sugimoto; Hiroyoshi Fujita; Hiroshi Wakao
Journal:  World J Stem Cells       Date:  2016-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.